Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator with beta-adrenergic agonist activity. It is thought to exert its effect by relaxing vascular smooth muscle and also has a direct stimulant effect on uterine and skeletal muscle.
## Primary Indications
* Peripheral vascular disease (e.g., arteriosclerosis obliterans, Raynaud's disease) to improve blood flow.
* Cerebrovascular insufficiency.
* Historically used for premature labor, but this use is not widely supported by current evidence and is generally not recommended due to safety concerns and lack of efficacy compared to other agents.
## Adult Dosing
* **Peripheral Vascular Disease/Cerebrovascular Insufficiency:** 10 mg to 20 mg orally every 3 to 4 times daily.
## Pediatric Dosing
No established pediatric dosing. Use is generally not recommended.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment. However, caution and close monitoring are advised in patients with significant impairment.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use immediately postpartum or in patients with heart disease (e.g., severe hypotension, tachycardia, arrhythmias) is generally contraindicated due to potential cardiovascular effects.
## Adverse Effects
* **Cardiovascular:** Tachycardia, hypotension, dizziness, flushing.
* **Gastrointestinal:** Nausea, vomiting, stomach pain, bloating.
* **Neurological:** Weakness, nervousness, headache.
* **Other:** Rash, drowsiness.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects.
* **Sympathomimetic agents:** Concurrent use may increase cardiovascular stimulation.
## Monitoring
* Blood pressure and heart rate.
* Symptoms of peripheral vascular disease (e.g., claudication, skin temperature, color).
* Signs of adverse effects.
## Clinical Pearls
* Isoxsuprine's efficacy in treating peripheral vascular disease is controversial, and clinical guidelines often do not recommend its routine use.
* Patients should be advised to take the medication with food if gastrointestinal upset occurs.
* Discontinuation may be necessary if symptoms worsen or significant adverse effects develop.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient management. Dosing and indications can change.
